Title and Organization:
Evan Melrose, MD, MBA, is managing director of Spindletop Capital, a healthcare private equity firm he founded in 2011 to provide expansion capital and operating expertise to transformational healthcare companies and exceptional entrepreneurs. With 25 years of experience across healthcare, Evan possesses extensive investment, clinical, and operating experience in research, clinical practice, education, and health policy. Prior to Spindletop Capital, Evan was founding managing director of PTV Sciences, a Texas based venture capital firm, and a director with Burrill & Company, a San Francisco-based life science private equity/venture capital firm. At Burrill he managed investments on behalf of partners including IBM, Aventis, P&G, Nestle, and Bayer. His board and operating experience include Bioventus, IntersectENT, BioForm Medical, Biomimetic Therapeutics, and Inhibitex. Evan has held faculty appointments at UCSF, UPENN, and Baylor College of Medicine. As a family physician, Evan continues to see patients and maintains licensure in several states. He has served on several non-profit boards including the Texas Business Hall of Fame Foundation, the University of Texas Hillel Foundation, the Texas Lyceum, and is a member of Young Presidents Organization. In 1996 he worked on Medicare reform as an American Medical Association health policy fellow and is the recipient of the AMA/Glaxo Wellcome Leadership Award. In 2013 the National Association of Corporate Directors (NACD) elected Evan as a NACD Board Leadership Fellow, their highest level of credentialing for corporate directors. Evan received his BA from the University of Pennsylvania, received an MD from Indiana University School of Medicine, and an MBA from The Wharton School. He is certified as a public company director by Institutional Shareholder Services/UCLA Anderson School of Business. Evan is a Fellow of the third class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.